Morsef Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.00 M
- Revenue Growth 43.10%
- Profit Growth 83.54%
- Ebitda 5.29%
- Net Worth 31.40%
- Total Assets -11.46%
About Morsef Pharmaceuticals
Morsef Pharmaceuticals Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 June 1999 and has a history of 25 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Cibien International Private Limited. The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.00 M.
Himanshu Bhatt, Shilpa Bhatt, and Atul Bhopale serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51900MH1999PTC120206
-
Company No.
120206
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Jun 1999
-
Date of AGM
01 Aug 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Morsef Pharmaceuticals Private Limited offer?
Morsef Pharmaceuticals Private Limited offers a wide range of products and services, including Pharmaceutical Machinery & Equipment, Pharmaceutical Machines.
Who are the key members and board of directors at Morsef Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Bhatt
|
Director | 04-Jun-1999 | Current |
|
Shilpa Bhatt
|
Director | 27-Jun-2012 | Current |
|
Atul Bhopale
|
Director | 29-May-2024 | Current |
Financial Performance of Morsef Pharmaceuticals.
Morsef Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.1% increase. The company also saw a substantial improvement in profitability, with a 83.54% increase in profit. The company's net worth Soared by an impressive increase of 31.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Morsef Pharmaceuticals?
In 2020, Morsef Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Wescan Solutions LlpHimanshu Bhatt is a mutual person
-
Cibien Drugs And Pharmaceuticals Pvt Ltd
Himanshu Bhatt and Atul Bhopale are mutual person
-
Morsef Machines Private Limited
Himanshu Bhatt is a mutual person
Charges (Loans)
₹7.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2021 | Others | ₹7.00 M | Open |
How Many Employees Work at Morsef Pharmaceuticals?
Unlock and access historical data on people associated with Morsef Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Morsef Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morsef Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
